InvestSMART

Antisense Therapeutics Limited (ASX: ANP) - Announcements

Current share price for ANP : $0.058 0.003 (4.92%)+

ASX company news and announcements for Antisense Therapeutics Limited (ANP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Antisense Therapeutics Limited (ANP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Antisense Therapeutics Limited (ANP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Antisense Therapeutics Limited (ANP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 ANP receives US FDA ODD for ATL1102 in DMD 26 Oct 2020 8:51AM $0.127 $0.058 fallen by 54.33%
$52 Trading Halt 22 Oct 2020 3:20PM $0.128 $0.058 fallen by 54.51%
$52 Pause in Trading 22 Oct 2020 2:59PM $0.128 $0.058 fallen by 54.51%
$52 Quarterly Update and Appendix 4C 21 Oct 2020 9:38AM $0.135 $0.058 fallen by 57.04%
$52 Ceasing to be a substantial holder from AEF 21 Oct 2020 9:24AM $0.135 $0.058 fallen by 57.04%
$52 Change in Substantial Holding from AEF 2 Oct 2020 3:07PM $0.130 $0.058 fallen by 55.38%
$52 ATL1102 shows significant improvement vs external control 2 Oct 2020 8:39AM $0.125 $0.058 fallen by 53.60%
$52 US FDA Grants RPDD to ATL1102 for the treatment of DMD 30 Sep 2020 9:55AM $0.115 $0.058 fallen by 49.57%
$52 Antisense to present new data at WMS Virtual Congress 2020 29 Sep 2020 11:57AM $0.115 $0.058 fallen by 49.57%
$52 Trading Halt 28 Sep 2020 9:30AM $0.115 $0.058 fallen by 49.57%
$52 Ceasing to be a substantial holder 22 Sep 2020 4:46PM $0.100 $0.058 fallen by 42%
$52 ANP Submits EU Orphan Drug application for ATL1102 in DMD 31 Aug 2020 9:35AM $0.091 $0.058 fallen by 36.26%
$52 Appendix 4E and Full Year Statutory Accounts 26 Aug 2020 5:02PM $0.091 $0.058 fallen by 36.26%
$52 ANP Submits US Orphan Drug application for ATL1102 in DMD 3 Aug 2020 9:35AM $0.078 $0.058 fallen by 25.64%
$52 Quarterly Update and Appendix 4C 31 Jul 2020 9:34AM $0.081 $0.058 fallen by 28.40%
$52 EMA DMD Scientific Advice and Regulatory Process Update 30 Jul 2020 9:35AM $0.100 $0.058 fallen by 42%
$52 ANP to participate at 2020 PPMD Virtual Annual Conference 16 Jul 2020 9:06AM $0.100 $0.058 fallen by 42%
$52 Appendix 2A 9 Jul 2020 12:44PM $0.105 $0.058 fallen by 44.76%
$52 Proposed issue of Securities - ANP 8 Jul 2020 6:35PM $0.094 $0.058 fallen by 38.30%
$52 ShareCafe Small Cap Hidden Gems Webinar Presentation 25 Jun 2020 4:16PM $0.064 $0.058 fallen by 9.38%
$52 ANP to Present at Webinar Hosted by PPMD in the US 17 Jun 2020 9:26AM $0.063 $0.058 fallen by 7.94%
$52 Poster Presentation MDA Virtual Conference 2020 11 Jun 2020 12:02PM $0.066 $0.058 fallen by 12.12%
$52 Change in substantial holding from AEF 25 May 2020 3:39PM $0.068 $0.058 fallen by 14.71%
$52 Trial Met Primary & Exceeded Secondary Endpoint Expectations 21 May 2020 6:41PM $0.048 $0.058 risen by 20.83%
$52 Trading Halt 20 May 2020 9:36AM $0.048 $0.058 risen by 20.83%

201 - 225 of 707 results

Page 9 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.